These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28085026)

  • 1. Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor.
    Niefind K; Bischoff N; Golub AG; Bdzhola VG; Balanda AO; Prykhod'ko AO; Yarmoluk SM
    Pharmaceuticals (Basel); 2017 Jan; 10(1):. PubMed ID: 28085026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'.
    Hochscherf J; Lindenblatt D; Witulski B; Birus R; Aichele D; Marminon C; Bouaziz Z; Le Borgne M; Jose J; Niefind K
    Pharmaceuticals (Basel); 2017 Dec; 10(4):. PubMed ID: 29236079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α' Structures.
    Lindenblatt D; Nickelsen A; Applegate VM; Hochscherf J; Witulski B; Bouaziz Z; Marminon C; Bretner M; Le Borgne M; Jose J; Niefind K
    ACS Omega; 2019 Mar; 4(3):5471-5478. PubMed ID: 31559376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Plasticity of Crystalline CK2α' Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity.
    Lindenblatt D; Applegate V; Nickelsen A; Klußmann M; Neundorf I; Götz C; Jose J; Niefind K
    J Med Chem; 2022 Jan; 65(2):1302-1312. PubMed ID: 34323071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
    Bollacke A; Nienberg C; Borgne ML; Jose J
    J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density crystal packing of human protein kinase CK2 catalytic subunit in complex with resorufin or other ligands: a tool to study the unique hinge-region plasticity of the enzyme without packing bias.
    Klopffleisch K; Issinger OG; Niefind K
    Acta Crystallogr D Biol Crystallogr; 2012 Aug; 68(Pt 8):883-92. PubMed ID: 22868753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α'.
    Bischoff N; Raaf J; Olsen B; Bretner M; Issinger OG; Niefind K
    Mol Cell Biochem; 2011 Oct; 356(1-2):57-65. PubMed ID: 21739153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional analysis of the flexible regions of the catalytic α-subunit of protein kinase CK2.
    Papinutto E; Ranchio A; Lolli G; Pinna LA; Battistutta R
    J Struct Biol; 2012 Feb; 177(2):382-91. PubMed ID: 22186626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β.
    Bischoff N; Olsen B; Raaf J; Bretner M; Issinger OG; Niefind K
    J Mol Biol; 2011 Mar; 407(1):1-12. PubMed ID: 21241709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin.
    Raaf J; Klopffleisch K; Issinger OG; Niefind K
    J Mol Biol; 2008 Mar; 377(1):1-8. PubMed ID: 18242640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit.
    Ermakova I; Boldyreff B; Issinger OG; Niefind K
    J Mol Biol; 2003 Jul; 330(5):925-34. PubMed ID: 12860116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2.
    Raaf J; Issinger OG; Niefind K
    J Mol Biol; 2009 Mar; 386(5):1212-21. PubMed ID: 19361447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a CK2α'-Biased ATP-Competitive Inhibitor from a High-Throughput Screen of an Allosteric-Inhibitor-Like Compound Library.
    Mudaliar D; Mansky RH; White A; Baudhuin G; Hawkinson J; Wong H; Walters MA; Gomez-Pastor R
    ACS Chem Neurosci; 2024 Aug; 15(15):2703-2718. PubMed ID: 38908003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CK2α' selective inhibitors by the screening of an allosteric-kinase-inhibitor-like compound library.
    Mudaliar D; Mansky RH; White A; Baudhuin G; Hawkinson J; Wong H; Walters MA; Gomez-Pastor R
    bioRxiv; 2024 Jan; ():. PubMed ID: 38328231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex Structures.
    Guerra B; Bischoff N; Bdzhola VG; Yarmoluk SM; Issinger OG; Golub AG; Niefind K
    ACS Chem Biol; 2015 Jul; 10(7):1654-60. PubMed ID: 25961323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational dynamics of human protein kinase CK2α and its effect on function and inhibition.
    Srivastava A; Hirota T; Irle S; Tama F
    Proteins; 2018 Mar; 86(3):344-353. PubMed ID: 29243286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selected flavonoid compounds as promising inhibitors of protein kinase CK2α and CK2α', the catalytic subunits of CK2.
    Baier A; Galicka A; Nazaruk J; Szyszka R
    Phytochemistry; 2017 Apr; 136():39-45. PubMed ID: 28043654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic activity of mutants of yeast protein kinase CK2alpha.
    Sajnaga E; Kubiński K; Szyszka R
    Acta Biochim Pol; 2008; 55(4):767-76. PubMed ID: 19015772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners.
    Litchfield DW; Bosc DG; Canton DA; Saulnier RB; Vilk G; Zhang C
    Mol Cell Biochem; 2001 Nov; 227(1-2):21-9. PubMed ID: 11827170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate.
    Yde CW; Ermakova I; Issinger OG; Niefind K
    J Mol Biol; 2005 Mar; 347(2):399-414. PubMed ID: 15740749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.